-
Mashup Score: 64Lung Cancer in Women: The Past, Present, and Future - 3 month(s) ago
Lung cancer is the leading cause of cancer death for women in multiple countries including the United States. Women are exposed to unique risk factors that remain largely understudied such as indoor pollution, second-hand tobacco exposure, biological differences, gender differences in tolerability and response to therapy in lung cancer, and societal gender roles, that create distinct survivorship needs. Women continue to lack representation in lung cancer clinical trials and are typically treated with data generated from majority male patient study populations, which may be inappropriate to extrapolate and generalize to females.
Source: www.clinical-lung-cancer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8Health Equity Week - 3 month(s) ago
Health Equity Week is an annual, weeklong virtual educational opportunity with an in-person keynote event.
Source: www.mcgaw.northwestern.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 64Lung Cancer in Women: The Past, Present, and Future - 3 month(s) ago
Lung cancer is the leading cause of cancer death for women in multiple countries including the United States. Women are exposed to unique risk factors that remain largely understudied such as indoor pollution, second-hand tobacco exposure, biological differences, gender differences in tolerability and response to therapy in lung cancer, and societal gender roles, that create distinct survivorship needs. Women continue to lack representation in lung cancer clinical trials and are typically treated with data generated from majority male patient study populations, which may be inappropriate to extrapolate and generalize to females.
Source: www.clinical-lung-cancer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Health Equity Week - 3 month(s) ago
Health Equity Week is an annual, weeklong virtual educational opportunity with an in-person keynote event.
Source: www.mcgaw.northwestern.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 64Lung Cancer in Women: The Past, Present, and Future - 3 month(s) ago
Lung cancer is the leading cause of cancer death for women in multiple countries including the United States. Women are exposed to unique risk factors that remain largely understudied such as indoor pollution, second-hand tobacco exposure, biological differences, gender differences in tolerability and response to therapy in lung cancer, and societal gender roles, that create distinct survivorship needs. Women continue to lack representation in lung cancer clinical trials and are typically treated with data generated from majority male patient study populations, which may be inappropriate to extrapolate and generalize to females.
Source: www.clinical-lung-cancer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 64Lung Cancer in Women: The Past, Present, and Future - 3 month(s) ago
Lung cancer is the leading cause of cancer death for women in multiple countries including the United States. Women are exposed to unique risk factors that remain largely understudied such as indoor pollution, second-hand tobacco exposure, biological differences, gender differences in tolerability and response to therapy in lung cancer, and societal gender roles, that create distinct survivorship needs. Women continue to lack representation in lung cancer clinical trials and are typically treated with data generated from majority male patient study populations, which may be inappropriate to extrapolate and generalize to females.
Source: www.clinical-lung-cancer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 64Lung Cancer in Women: The Past, Present, and Future - 3 month(s) ago
Lung cancer is the leading cause of cancer death for women in multiple countries including the United States. Women are exposed to unique risk factors that remain largely understudied such as indoor pollution, second-hand tobacco exposure, biological differences, gender differences in tolerability and response to therapy in lung cancer, and societal gender roles, that create distinct survivorship needs. Women continue to lack representation in lung cancer clinical trials and are typically treated with data generated from majority male patient study populations, which may be inappropriate to extrapolate and generalize to females.
Source: www.clinical-lung-cancer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Cancer: Vol 130, No 3 - 4 month(s) ago
Click on the title to browse this issue
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Cancer epidemiology is the study of the causes of cancer and the evaluation of outcomes in defined population groups. As a population science, epidemiology plays an important role in cancer prevention and control with discoveries leading to improved guidelines, practices, and policies with wide-reaching public health impact. Individuals or population groups at increased risk of cancer or poor outcomes can be targeted for risk factor modification, increased surveillance, and preven tion and intervention
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 55New Registry Aims to Expand Knowledge of Lung Cancer Treatment During Pregnancy - ILCN.org (ILCN/WCLC) - 4 month(s) ago
Dr. Narjust Florez, who is spearheading the effort at Dana Farber, says the need for research on cancer therapies for pregnant patients is urgent as both maternal age and the number of young lung cancer diagnoses are increasing.
Source: www.ilcn.orgCategories: General Medicine News, Hem/OncsTweet
🗣️📖Check out our review about Lung Cancer in women @ClinicalLung Lung Cancer in Women: The Past, Present, and Future🫁 @LeciaSequist @Florez_Lab @IvyLorena_Md @IvyRadOncMD @ShrutiPatelMD @NishwantS https://t.co/Wi3kuYiSPk